Bone marrow transplantation temporarily improves pancreatic function in streptozotocin-induced diabetes: Potential involvement of very small embryonic-like cells

Transplantation

Volumn 89, Issue 6, 2010, Pages 677-685

  Huang, Yiming ^a   Kucia, Magda ^a   Hussain, Lala Rukh ^a   Wen, Yujie ^a   Xu, Hong ^a   Yan, Jun ^a   Ratajczak, Mariusz Z ^a   Ildstad, Suzanne T ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

cell regeneration; Bone marrow; Pancreatic; Stem cells; Transplantation

Indexed keywords

MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW TRANSPLANTATION; CELL REGENERATION; CONTROLLED STUDY; EMBRYO CELL; HYPERGLYCEMIA; MALE; MOUSE; NONHUMAN; PANCREAS FUNCTION; PANCREAS INJURY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOZOCIN DIABETES; UPREGULATION;

ANIMALS; ANTIGENS, CD45; BLOOD GLUCOSE; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; CHEMOKINE CXCL12; CHEMOTAXIS; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GRANULOCYTE COLONY-STIMULATING FACTOR; GREEN FLUORESCENT PROTEINS; INSULIN; INSULIN-SECRETING CELLS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; REGENERATION; RNA, MESSENGER; TIME FACTORS; TRANSPLANTATION CHIMERA;

EID: 77949888203     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181c9dc7d     Document Type: Article

References (52)

1. Krause DS, Theise ND, Collector MI, et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001; 105: 369.
2. Brazelton TR, Rossi FM, Keshet GI, et al. From marrow to brain: Expression of neuronal phenotypes in adult mice. Science 2000; 290:1775.
3. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41.
4. Bonner-Weir S, TanejaM, Weir GC, et al. In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci USA 2000; 97: 7999.
5. Dor Y, Brown J, Martinez OI, et al. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004; 429: 41.
6. Bonner-Weir S, Weir GC. New sources of pancreatic beta-cells. Nat Biotechnol 2005; 23: 857.
7. Ratajczak MZ, Zuba-Surma EK, Machalinski B, et al. Very small embryonic-like (VSEL) stem cells: Purification from adult organs, characterization, and biological significance. Stem Cell Rev 2008; 4: 89.
8. Kucia M, Reca R, Campbell FR, et al. A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4(+) stem cells identified in adult bone marrow. Leukemia 2006; 20: 857.
9. Kaufman CL, Li H, Ildstad ST. Patterns of hemopoietic reconstitution in nonobese diabetic mice: Dichotomy of allogeneic resistance versus competitive advantage of disease-resistant marrow. J Immunol 1997; 158: 2435.
10. Li H, Kaufman CL, Boggs SS, et al. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in non-obese diabetic (NOD) mice. J Immunol 1996; 156: 380.
11. Zorina TD, Subbotin VM, Bertera S, et al. Recovery of the endogenous beta cell function in the NOD model of autoimmune diabetes. Stem Cells 2003; 21: 377.
12. Ianus A, Holz GG, Theise ND, et al. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 2003; 111: 843.
13. WenY, OuyangJ, Yang R, et al. Reversal of new-onset type 1 diabetes in mice by syngeneic bone marrow transplantation. Biochem Biophys Res Commun 2008; 374: 282.
14. Lechner A, Yang YG, Blacken RA, et al. No evidence for significant transdifferentiation of bone marrow into pancreatic beta-cells in vivo. Diabetes 2004; 53: 616.
15. TaneeraJ, RosengrenA, RenstromE, et al. Failure of transplanted bone marrow cells to adopt a pancreatic beta-cell fate. Diabetes 2006; 55:290.
16. Hess D, Li L, Martin M, et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 2003; 21: 763.
17. Hasegawa Y, Ogihara T, Yamada T, et al. Bone marrow (BM) transplantation promotes beta-cell regeneration after acute injury through BM cell mobilization. Endocrinology 2007; 148: 2006.
18. Banerjee M, Kumar A, Bhonde RR. Reversal of experimental diabetes by multiple bone marrow transplantation. Biochem Biophys Res Commun 2005; 328: 318.
19. Than S, Ishida H, Inaba M, et al. Bone marrow transplantation as a strategy for treatment of non-insulin-dependent diabetes mellitus in KK-Ay mice. JExp Med 1992; 176: 1233.
20. Huang Y, Ratajczak MZ, Reca R, et al. Flt3 expression discriminates HSC subpopulations with differing engraftment-potential: Identifying the most potent combination. Transplantation 2008; 85: 1175.
21. Wysoczynski M, Reca R, Ratajczak J, et al. Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient. Blood 2005; 105:40.
22. Neipp M, Zorina T, Domenick MA, et al. Effect of FLT3 ligand and granulocyte colony-stimulating factor on expansion and mobilization of facilitating cells and hematopoietic stem cells in mice: Kinetics and repopulating potential. Blood 1998; 92: 3177.
23. Dawn B, Guo Y, Rezazadeh A, et al. Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function. Circ Res 2006; 98: 1098.
24. Jackson KA, Mi T, Goodell MA. Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sci USA 1999; 96: 14482.
25. Lagasse E, Connors H, Al Dhalimy M, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000; 6:1229.
26. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701.
27. Wagers AJ, Sherwood RI, Christensen JL, et al. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 2002; 297: 2256.
28. Zuba-Surma EK, Kucia M, Dawn B, et al. Bone marrow-derived pluri-potent very small embryonic-like stem cells (VSELs) are mobilized after acute myocardial infarction. J Mol Cell Cardiol 2008; 44: 865.
29. + very small embryonic-like stem cells in patients with actue myocardial infarction. J Am Coll Cardiol 2009; 53:1.
30. Kucia MJ, Wysoczynski M, Wu W, et al. Evidence that very small embryonic-like stem cells are mobilized into peripheral blood. Stem Cells 2008; 26: 2083.
31. Wang X, Ge S, Gonzalez I, et al. Formation of pancreatic duct epithelium from bone marrow during neonatal development. Stem Cells 2006; 24: 307.
32. Grapin-Botton A, Heimberg H, Lemaigre F. The genetic programme of pancreatic beta-cells: Basic science for the development of beta-cell therapy. Workshop on programming pancreatic beta-cells. EMBO Rep 2007; 8: 322.
33. Kim SK, MacDonald RJ. Signaling and transcriptional control of pancreatic organogenesis. Curr Opin Genet Dev 2002; 12: 540.
34. Jonsson J, Carlsson L, Edlund T, et al. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 1994; 371: 606.
35. Holland AM, Gonez LJ, Naselli G, et al. Conditional expression demonstrates the role of the homeodomain transcription factor Pdx1 in maintenance and regeneration of beta-cells in the adult pancreas. Diabetes 2005; 54: 2586.
36. KoyaV, LuS, SunYP, et al. Reversal of streptozotocin-induced diabetes in mice by cellular transduction with recombinant pancreatic transcription factor pancreatic duodenal homeobox-1: A novel protein transduction domain-based therapy. Diabetes 2008; 57: 757.
37. Schwitzgebel VM, Scheel DW, Conners JR, et al. Expression of neurogenin3 reveals an islet cell precursor population in the pancreas. Development 2000; 127: 3533.
38. Esni F, Ghosh B, Biankin AV, et al. Notch inhibits Ptf1 function and acinar cell differentiation in developing mouse and zebrafish pancreas. Development 2004; 131: 4213.
39. Geminder H, Sagi-Assif O, Goldberg L, et al. A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma. J Immunol 2001; 167: 4747.
40. Libura J, Drukala J, Majka M, et al. CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion. Blood 2002; 100: 2597.
41. Ratajczak MZ, Kucia M, Reca R, et al. Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells 'hide out' in the bone marrow. Leukemia 2004; 18: 29.
42. Kucia M, Ratajczak J, Reca R, et al. Tissue-specific muscle, neural and liver stem/progenitor cells reside in the bone marrow, respond to an SDF-1 gradient and are mobilized into peripheral blood during stress and tissue injury. Blood Cells Mol Dis 2004; 32: 52.
43. Ratajczak MZ, Majka M, Kucia M, et al. Expression of functional CXCR4 by muscle satellite cells and secretion of SDF-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrow and hematopoietic stem/progenitor cells in muscles. Stem Cells 2003; 21: 363.
44. Kayali AG, Van Gunst K, Campbell IL, et al. The stromal cell-derived factor-1alpha/CXCR4 ligand-receptor axis is critical for progenitor survival and migration in the pancreas. J Cell Biol 2003; 163: 859.
45. Kucia M, Dawn B, Hunt G, et al. Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood following myocardial infarction. CircRes 2004; 95: 1191.
46. Yamaguchi J, Kusano KF, Masuo O, et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003; 107: 1322.
47. Kollet O, Shivtiel S, Chen YQ, et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest 2003; 112: 160.
48. Gianni AM, Bregni M, Siena S, et al. Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients. J Clin Oncol 1992; 10: 1955.
49. Haas R, Ho AD, Bredthauer U, et al. Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor. Exp Hematol 1990; 18: 94.
50. Papaccio G, Frascatore S, Esposito V, et al. Early macrophage infiltration in mice treated with low-dose streptozotocin decreases islet superoxide dismutase levels: Prevention by silica pretreatment. Acta Anat (Basel) 1991; 142: 141.
51. Brasel K, McKenna HJ, Morrissey PJ, et al. Hematologic effects of flt3 ligand in vivo in mice. Blood 1996; 88: 2004.
52. Chilton PM, Rezzoug F, Fugier-Vivier I, et al. Flt3-Ligand Treatment Prevents Diabetes in NOD Mice. Diabetes 2004; 53: 1995.